Role of Steroids and 10% Hypertonic Sodium Chloride in Adhesiolysis in Post Lumbar Surgery Syndrome Patients
CompletedNot applicableNCT01053572
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To evaluate the effectiveness of steroids and/or 10% hypertonic sodium chloride in percutaneous adhesiolysis in managing chronic low back and/or lower extremity pain in patients with post lumbar surgery syndrome. To evaluate and compare the adverse event profile in all groups.
Study details
- Official title
- Evaluation of the Role of Steroids and 10% Hypertonic Sodium Chloride in Adhesiolysis in Post Lumbar Surgery Syndrome Patients: A Prospective, Randomized, Double-Blind, Equivalence, Controlled Trial of Percutaneous Lumbar Adhesiolysis
- Conditions
- Interventions
- Procedure: Adhesiolysis
- Sponsor
- Pain Management Center of Paducah
- Start date
- 2010-02
- Primary completion
- 2012-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Inclusion criteria: * History of lumbar surgery of at least 6 months duration in the past * Patients over the age of 18 years * Patients with a history of chronic function-limiting low back pain with or without lower extremity pain of at least 6 months duration (post-surgery) * Patients who are competent to understand the study protocol and provide voluntary, written informed consent and participate in outcome measurements. Exclusion criteria: * Facet joints, uncontrollable as sole pain generators * Unstable or heavy opioid use (400 mg of morphine equivalents daily) * Uncontrolled psychiatric disorders * Uncontrolled medical illness * Any conditions that could interfere with the interpretation of the outcome assessments * Pregnant or lactating women * Patients with a history or potential for adverse reaction(s) to local anesthetic, steroids, or hypertonic sodium chloride solution.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01053572